findmyKOL
Clinical trialNCT06445114RecruitingPhase 2Interventional

Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer

SponsorZachary ZumstegEnrollment50CarcinomaOropharyngeal Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Cedars-Sinai Cancer at Beverly Hills (tho)

    Beverly Hills, California, United States

    David Hoffman, MDJeremy Lorber, MDKamalesh Sankhala, MDKevin Scher, MDLeland Green, MD
    Recruiting
  • Cedars Sinai Medical Center

    Los Angeles, California, United States

    Alain Mita, MDAllen Ho, MDEvan Walgama, MDJon Mallen-St. Clair, MDJulie Jang, MDJun Gong, MDRonald Natale, MDStephen Shiao, MDZachary S Zumsteg, MD
    Recruiting
  • Cs Cancer at Valley Oncology Medical Group

    Tarzana, California, United States

    Anirban Balmanoukian, MDBenjamin L King, MDJohnny K Chang, MDNatasha Banerjee, MDRobert S Reznik, MDRyan Ponec, MD
    Recruiting
  • Cs Cancer at the Hunt Cancer Center

    Torrance, California, United States

    Andrew Horodner, MDAndrew Schumacher, MDBryan Chang, MDDavid Chan, MDHugo Hool, MDRebecca Philipson, MDSwati Sikaria, MDSyed Jilani, MDThomas Lowe, MDThyra Endicott, MDUsama Mahmood, MDVanessa Dickey, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
12 May 2025
Primary completion
30 Jun 2032
Completion
30 Jun 2032
Last update posted
8 May 2026
Registered enrollment
50
Registry id
NCT06445114

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.